Withholding e-cigarettes as an alternative from smokers who are unable to quit equals supporting the continued use of conventional cigarettes, said David Abrams, a member of the National Tobacco Reform Initiative.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
